Protica Bio
Leveraging proteomics and machine learning for improved immunotherapy decisions and drug discovery.
About
Technology stack
detected 2026-06-17No comments yet. Be the first to share your take.
What does Protica Bio do?
Protica Bio develops predictive biomarkers by combining proteomics and computational biology to make cancer treatments more effective, personalized, and accessible. Their proprietary platform offers unmatched protein coverage to reveal real-time biological signals that predict treatment response and uncover new therapeutic targets for cancer immunotherapy. They serve the oncology field by identifying novel drug targets and immune checkpoint inhibitor (ICI) response markers.
Where is Protica Bio headquartered?
Protica Bio is headquartered in Cambridge, United States.
When was Protica Bio founded?
Protica Bio was founded in 2022.
What industry does Protica Bio operate in?
Protica Bio operates in Life Sciences, Computational Biology, Proteomics, Immunotherapy, Drug Discovery, Biotech.
How many employees does Protica Bio have?
Protica Bio has approximately 2 people on record.